
TriMas Corporation (NASDAQ:TRS – Free Report) – Stock analysts at Zacks Research issued their FY2028 EPS estimates for shares of TriMas in a report issued on Thursday, March 12th. Zacks Research analyst Team forecasts that the industrial products company will earn $2.14 per share for the year. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share.
TRS has been the topic of several other research reports. BWS Financial reaffirmed a “buy” rating and set a $45.00 target price on shares of TriMas in a research note on Monday, March 2nd. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research report on Monday, December 29th. Wall Street Zen cut shares of TriMas from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $38.00 price objective on shares of TriMas in a research report on Thursday, February 26th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, TriMas has a consensus rating of “Hold” and an average target price of $41.50.
TriMas Stock Down 0.7%
NASDAQ:TRS opened at $35.04 on Friday. The business’s fifty day moving average price is $35.94 and its 200 day moving average price is $36.01. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of 11.80 and a beta of 0.55. The company has a current ratio of 2.52, a quick ratio of 1.93 and a debt-to-equity ratio of 0.66. TriMas has a 1-year low of $19.45 and a 1-year high of $42.00.
TriMas (NASDAQ:TRS – Get Free Report) last announced its earnings results on Thursday, February 26th. The industrial products company reported $0.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.01). The firm had revenue of ($139.97) million for the quarter, compared to analyst estimates of $192.96 million. TriMas had a net margin of 11.53% and a return on equity of 12.04%. TriMas’s revenue for the quarter was up 12.4% compared to the same quarter last year. During the same period last year, the firm earned $0.43 earnings per share.
Hedge Funds Weigh In On TriMas
Several institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of TriMas by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company’s stock worth $565,000 after acquiring an additional 1,014 shares in the last quarter. Jane Street Group LLC bought a new position in shares of TriMas in the 1st quarter valued at approximately $868,000. AE Wealth Management LLC acquired a new stake in TriMas in the 2nd quarter worth approximately $212,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in TriMas in the 2nd quarter worth approximately $230,000. Finally, LSV Asset Management bought a new stake in TriMas during the second quarter worth approximately $498,000. 99.42% of the stock is currently owned by institutional investors.
TriMas Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 27th were issued a $0.04 dividend. The ex-dividend date was Friday, February 27th. This represents a $0.16 dividend on an annualized basis and a yield of 0.5%. TriMas’s dividend payout ratio is currently 5.39%.
About TriMas
TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.
The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.
Featured Articles
- Five stocks we like better than TriMas
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- This coin has everything going for it
- Only 500 people today…
- The gold chart Wall Street is terrified of…
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.
